ArticleAACE endocrinology and diabetes
Multidisciplinary Management in the Diabetes Reversal Clinic Promotes Diabetes Remission.
Article in AACE endocrinology and diabetes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objective: To investigate the remission rate and metabolic outcomes under the Diabetes Reversal Clinic with multidisciplinary management. Methods: Patients with type 2 diabetes who visited the Diabetes Reversal Clinic from April 2022 to December 2024 were enrolled. Baseline characteristics and metabolic indicators were recorded. Participants received comprehensive multidisciplinary management including personalized treatment plans, structured lifestyle modification, continuous glucose monitoring, and traditional Chinese medicine as adjunctive therapy. After 6 months, the remission rate, the rate of target glycated hemoglobin A1c < 53 mmol/mol (7.0%), and changes of metabolic indicators in patients were analyzed. Results: Our major results found that, among 171 patients with type 2 diabetes who were followed for more than 6 months, 50 (29.24%) patients achieved remission and 149 (87.13%) patients achieved the target of glycated hemoglobin A1c < 53 mmol/mol (7.0%). At the end of 2022, 2023, and 2024, the annual diabetes remission rate reached 6.12% (6/98), 16.78% (25/149), and 16.24% (19/117), respectively. The multidisciplinary management significantly decreased body mass index, waist circumference, waist-to-height ratio, fasting blood glucose, glycated hemoglobin A1c, and homeostasis model assessment of insulin resistance, while significantly increasing high-density lipoprotein cholesterol (all Conclusion: A diabetes remission rate of 29.24% and a target rate of 87.13% were obtained after 6 months of multidisciplinary management among patients with type 2 diabetes in the Diabetes Reversal Clinic. Our findings suggest that the multidisciplinary management model employed in the Diabetes Reversal Clinic is superior to conventional management in general outpatient clinics for promoting diabetes remission and metabolic reversal.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.